"Receptors, Interferon" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Specific molecular sites or structures on or in cells with which interferons react or to which they bind in order to modify the function of the cells. Interferons exert their pleiotropic effects through two different receptors. alpha- and beta-interferon crossreact with common receptors, while gamma-interferon initiates its biological effects through its own specific receptor system.
| Descriptor ID |
D017471
|
| MeSH Number(s) |
D12.776.543.750.705.852.400
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Interferon".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Interferon".
This graph shows the total number of publications written about "Receptors, Interferon" by people in this website by year, and whether "Receptors, Interferon" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2010 | 1 | 1 | 2 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2017 | 6 | 4 | 10 |
| 2018 | 2 | 3 | 5 |
| 2019 | 1 | 2 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Interferon" by people in Profiles.
-
Between immunomodulation and immunotolerance: The role of IFN? in SARS-CoV-2 disease. Cytokine. 2021 10; 146:155637.
-
Janus kinase signaling as risk factor and therapeutic target for severe SARS-CoV-2 infection. Eur J Immunol. 2021 05; 51(5):1071-1075.
-
May interferon ? be a novel therapeutic approach against COVID-19? Med Hypotheses. 2021 01; 146:110351.
-
Type I and III interferons disrupt lung epithelial repair during recovery from viral infection. Science. 2020 08 07; 369(6504):712-717.
-
LINE-1-Mediated AluYa5 Insertion Underlying Complete Autosomal Recessive IFN-?R1 Deficiency. J Clin Immunol. 2019 10; 39(7):739-742.
-
Type-Specific Crosstalk Modulates Interferon Signaling in Intestinal Epithelial Cells. J Interferon Cytokine Res. 2019 10; 39(10):650-660.
-
Lipopolysaccharide and interferon-? team up to activate HIF-1a via STAT1 in normoxia and exhibit sex differences in human aortic valve interstitial cells. Biochim Biophys Acta Mol Basis Dis. 2019 09 01; 1865(9):2168-2179.
-
IFN-? and CD25 drive distinct pathologic features during hemophagocytic lymphohistiocytosis. J Allergy Clin Immunol. 2019 06; 143(6):2215-2226.e7.
-
Evaluation of interleukin-12 receptor ß1 and interferon gamma receptor 1 deficiency in patients with disseminated BCG infection. Allergol Immunopathol (Madr). 2019 Jan - Feb; 47(1):38-42.
-
Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication. PLoS Pathog. 2018 08; 14(8):e1007246.